Servais A, Janssen MCH, Blakey H, Greco M, Lemoine S, Martin-Moreno PL, Game D, Levtchenko E, Lipkin G
Among these staining results, positive results for Olig-2 and GFAP supported glioma as an important differential ( Most MPNSTs in the cranial nerve show hyperintensity on T2WI and FLAIR, hypo- or iso-intensity on T1WI, and a homogeneous enhancement effect of contrast media on MRI ( Depending on the site of origin, MPNST treatment includes local therapy, such as surgical resection ( Neoplastic diseases affecting the CNS commonly develop in middle and advanced ages and have a subacute or chronic progressive course
However, compounded medications are not FDA-approved , which means their safety, efficacy, and quality are not guaranteed in the same way as brand-name drugs
It does not interfere with systemic peptide protocols and can be incorporated alongside existing regimens without timing conflicts
Acknowledgments We thank Madalyn Fritch for the help in histology staining
Switching from orforglipron to an injectable GLP-1 is simpler pharmacokinetically, since orforglipron's effects clear within a day or two of the last dose
